¿Qué tratamientos están aprobados para niños y jóvenes con EM?
We look into these in more detail to understand how the treatment decisions are made by regulators.
¿Cómo afectan diferentes TME la respuesta a la vacuna contra la COVID-19 de las personas?
Researchers in Israel have published the results of a small study exploring how well the Pfizer-BioNtech COVID-19 vaccine protects people with MS taking cladribine, fingolimod or ocrelizumab.
European Medicines Agency reviews safety of alemtuzumab
EMA conducts safety review of alemtuzumab (Lemtrada)
New generation treatments safe to use in children with MS
Clinical trials are rarely conducted in children with MS, but a new study has shown that new generation medications are safe to use in children with MS.